Terms: = Gastric cancer AND CEACAM5, CEA AND Treatment
344 results:
1. Predicting survival in locally advanced gastric cancer using prognostic factors - neoadjuvant rectal score and downstaging depth score.
Tamam S; Culcu S; Erözkan K; Benk MŞ; Azılı C; Altınsoy E; Ersöz Ş; Unal AE
S Afr J Surg; 2024 Mar; 62(1):72-79. PubMed ID: 38568130
[TBL] [Abstract] [Full Text] [Related]
2. [High expression of CPNE3 correlates with poor long-term prognosis of gastric cancer by inhibiting cell apoptosis
Duan T; Zhang Z; Shi J; Xiao L; Yang J; Yin L; Zhang X; Geng Z; Lu G
Nan Fang Yi Ke Da Xue Xue Bao; 2024 Jan; 44(1):129-137. PubMed ID: 38293984
[TBL] [Abstract] [Full Text] [Related]
3. Comprehensive Evaluation of Traditional Herbal Medicine Combined With Adjuvant Chemotherapy on Post-Surgical gastric cancer: A Systematic Review and Meta-Analysis.
Kim SD; Kim JH; Kim DH; Park JH; Gong Y; Sun C; Yoo HS; Park SJ
Integr Cancer Ther; 2024; 23():15347354231226256. PubMed ID: 38281123
[TBL] [Abstract] [Full Text] [Related]
4. [A Case of gastric cancer with Pulmonary Carcinomatous Lymphangitis and Disseminated Carcinomatosis of the Bone Marrow Responding to S-1 plus Cisplatin Chemotherapy].
Otsuka N; Shirayama K
Gan To Kagaku Ryoho; 2023 Dec; 50(12):1319-1321. PubMed ID: 38247072
[TBL] [Abstract] [Full Text] [Related]
5. Prediction Model of Ocular Metastases in gastric Adenocarcinoma: Machine Learning-Based Development and Interpretation Study.
Zou J; Shen YK; Wu SN; Wei H; Li QJ; Xu SH; Ling Q; Kang M; Liu ZL; Huang H; Chen X; Wang YX; Liao XL; Tan G; Shao Y
Technol Cancer Res Treat; 2024; 23():15330338231219352. PubMed ID: 38233736
[No Abstract] [Full Text] [Related]
6. A Single-Arm Phase II Study of Nab-Paclitaxel Plus Gemcitabine and Cisplatin for Locally Advanced or Metastatic Biliary Tract cancer.
Liu T; Li Q; Lin Z; Liu C; Pu W; Zeng S; Lai J; Cai X; Zhang L; Wang S; Chen M; Cao W; Gou H; Zhu Q
Cancer Res Treat; 2024 Apr; 56(2):602-615. PubMed ID: 37846469
[TBL] [Abstract] [Full Text] [Related]
7. The Leser-Trélat Sign in a Patient with gastric Adenocarcinoma.
Geber A; Hadžavdić A; Ljubojević Hadžavdić S
Acta Dermatovenerol Croat; 2023 Aug; 31(1):51-52. PubMed ID: 37843094
[TBL] [Abstract] [Full Text] [Related]
8. Tusamitamab Ravtansine in Patients with Advanced Solid Tumors: Phase I Study of Safety, Pharmacokinetics, and Antitumor Activity Using Alternative Dosing Regimens.
Tabernero J; Bedard PL; Bang YJ; Vieito M; Ryu MH; Fagniez N; Chadjaa M; Soufflet C; Masson N; Gazzah A
Cancer Res Commun; 2023 Aug; 3(8):1662-1671. PubMed ID: 37645622
[TBL] [Abstract] [Full Text] [Related]
9. MOF-Based Biosensors for the Detection of Carcinoembryonic Antigen: A Concise Review.
Ibrahim MR; Greish YE
Molecules; 2023 Aug; 28(16):. PubMed ID: 37630221
[TBL] [Abstract] [Full Text] [Related]
10. An autopsy case of alpha-fetoprotein-producing large duodenal adenocarcinoma.
Hirota S; Naganuma A; Kobayashi R; Suzuki Y; Hoshino T; Yasuoka H; Tanaka Y; Uraoka T; Kakizaki S
Clin J Gastroenterol; 2023 Dec; 16(6):829-835. PubMed ID: 37594614
[TBL] [Abstract] [Full Text] [Related]
11. Using Normalized Carcinoembryonic Antigen and Carbohydrate Antigen 19 to Predict and Monitor the Efficacy of Neoadjuvant Chemotherapy in Locally Advanced gastric cancer.
Tang XH; Wu XL; Gan XJ; Wang YD; Jia FZ; Wang YX; Zhang Y; Gao XY; Li ZY
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569566
[TBL] [Abstract] [Full Text] [Related]
12. Efficacy of the low dose apatinib plus deep hyperthermia as third-line or later treatment in HER-2 negative advanced gastric cancer.
Han G; Sun C; Cui L; Huang Y; Yu L; Liu S; Tao M
Pathol Oncol Res; 2023; 29():1611114. PubMed ID: 37465317
[No Abstract] [Full Text] [Related]
13. Incidence, clinicopathological features, and clinical outcomes of low HER2 expressed, inoperable, advanced, or recurrent gastric/gastroesophageal junction adenocarcinoma.
Nakayama I; Takahari D; Chin K; Wakatsuki T; Takamatsu M; Yamamoto N; Ogura M; Ooki A; Fukuda K; Osumi H; Fukuoka S; Shinozaki E; Yamaguchi K
ESMO Open; 2023 Aug; 8(4):101582. PubMed ID: 37348349
[TBL] [Abstract] [Full Text] [Related]
14. Evaluation of peritoneal Carcinoembryonic Antigen as a survival prognostic factor in gastric cancer patients: a single western center experience.
Natalizi N; Marino E; Graziosi L; Donini A
Updates Surg; 2023 Aug; 75(5):1211-1217. PubMed ID: 37347355
[TBL] [Abstract] [Full Text] [Related]
15. Identification of high-risk factors associated with mortality at 1-, 3-, and 5-year intervals in gastric cancer patients undergoing radical surgery and immunotherapy: an 8-year multicenter retrospective analysis.
Liu Y; Wang L; Du W; Huang Y; Guo Y; Song C; Tian Z; Niu S; Xie J; Liu J; Cheng C; Shen W
Front Cell Infect Microbiol; 2023; 13():1207235. PubMed ID: 37325512
[TBL] [Abstract] [Full Text] [Related]
16. Analysis of influencing factors of nerve invasion in locally advanced gastric cancer.
Ren XC; Liang P
Abdom Radiol (NY); 2023 Sep; 48(9):3005-3011. PubMed ID: 37289214
[TBL] [Abstract] [Full Text] [Related]
17. Ginseng-containing traditional medicine preparations in combination with fluoropyrimidine-based chemotherapy for advanced gastric cancer: A systematic review and meta-analysis.
Hu J; Cheng M; Li Y; Shi B; He S; Yao Z; Jiang J; Yu H; He Z; Zhao Y; Zheng H; Hua B; Liu R
PLoS One; 2023; 18(4):e0284398. PubMed ID: 37068063
[TBL] [Abstract] [Full Text] [Related]
18. Lymphovascular or perineural invasion is associated with lymph node metastasis and survival outcomes in patients with gastric cancer.
Zhang F; Chen H; Luo D; Xiong Z; Li X; Yin S; Jin L; Chen S; Peng J; Lian L
Cancer Med; 2023 Apr; 12(8):9401-9408. PubMed ID: 36952439
[TBL] [Abstract] [Full Text] [Related]
19. Pre-therapeutic molecular biomarkers of pathological response to neoadjuvant chemotherapy in gastric and esophago-gastric junction adenocarcinoma: A systematic review and meta-analysis.
Nurczyk K; Nowak N; Carlson R; Skoczylas T; Wallner G
Adv Med Sci; 2023 Mar; 68(1):138-146. PubMed ID: 36944288
[TBL] [Abstract] [Full Text] [Related]
20. The importance of CA 72-4 and CA 19-9 dosing in gastric cancer.
Roșu MC; Ardelean A; Moldovan SD; Faur FI; Nesiu A; Totoloci BD
J Med Life; 2023 Feb; 16(2):186-188. PubMed ID: 36937484
[TBL] [Abstract] [Full Text] [Related]
[Next]
